Clinical trials: Injury Due to Endoscopic Examination

Upper Gastrointestinal Bleeding

UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD

• Completed
• Age: 20 years and older
• Injection or infusion
• Medical device

UI-EWD (NextBiomedical Co, Incheon, South Korea), a new hemostatic powder for endoscopic treatment of high-risk bleeding peptic ulcers and bleeding after ESD/EMR.

Trial name

NCT02978391

Testing

UI-EWD Hemostatic system, epinephrine endoscopic injection (conventional therapy)

Where

2 sites in South Korea

Volunteers

76 people

Sponsor

Next Biomedical Co., Ltd.